EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2024 to stockholders of record at the close of business on December 6, 2024.

About embecta

embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit  or follow our social channels on , , and .

Contacts:
  
Media

Christian Glazar

Sr. Director, Corporate Communications

908-821-6922

Investors

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547





EN
26/11/2024

Underlying

EMBCEMBECTA CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Confe...

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 15, 2025 at 7:30 a.m. PT / 10:30 a.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at . About embecta embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery...

December 19, 2024 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financi...

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2024. "We are pleased to report a strong fourth quarter and end to our fiscal year, as we once again delive...

November 26, 2024 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2024 to stockholders of record at the close of business on December 6, 2024. About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions,...

November 26, 2024 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Fi...

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024. Those who would like to participate may access the live webcast , or access the ...

November 12, 2024 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial R...

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Thursday, November 26, 2024. Those who would like to participate may access the live webcast , or access the teleconf...

November 12, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch